Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2020]

Zamtocabtagene autoleucel improves event-free survival vs standard of care in...

Prof Peter Borchmann - University Hospital of Cologne, Cologne, Germany

Zamtocabtagene autoleucel improves event-free survival vs standard of care in second-line r/r LBCL ( Prof Peter Borchmann - University Hospital of Cologne, Cologne, Germany )

Anitocabtagene autoleucel achieves deep and durable responses in relapsed...

Dr Krina Patel - MD Anderson Cancer Center, Houston, USA

$Anitocabtagene autoleucel achieves deep and durable responses in relapsed/refractory multiple myelomas ( Dr Krina Patel - MD Anderson Cancer Center, Houston, USA )$

IP6K1-driven tumour polyphosphate may contribute to immune checkpoint inhibitor...

Dr Keith McCrae - Cleveland Clinic, Cleveland, USA

IP6K1-driven tumour polyphosphate may contribute to immune checkpoint inhibitor-associated thrombosis ( Dr Keith McCrae - Cleveland Clinic, Cleveland, USA )

Exploring genomic insights in acute lymphoblastic leukaemia treatment

Prof Charles Mullighan - St. Jude Children's Research Hospital, Memphis, USA

Exploring genomic insights in acute lymphoblastic leukaemia treatment ( Prof Charles Mullighan - St. Jude Children's Research Hospital, Memphis, USA )

New genomic map of adult B-ALL identifies CEBPalt subgroup and highlights...

Dr Xiaoming Zhong - St. Jude Children's Research Hospital, Memphis, USA

New genomic map of adult B-ALL identifies CEBPalt subgroup and highlights blinatumomab benefits in key high-risk molecular types ( Dr Xiaoming Zhong - St. Jude Children's Research Hospital, Memphis, USA )

Tec-Dara significantly improves PFS and OS compared to SoC in relapsed...

Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA

$Tec-Dara significantly improves PFS and OS compared to SoC in relapsed/refractory multiple myeloma ( Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA )$

Racial disparities in AML: Black patients show inferior survival despite...

Prof Shella Saint Fleur-Lominy - University of Maryland School of Medicine...

Racial disparities in AML: Black patients show inferior survival despite similar cytogenetics and treatment response ( Prof Shella Saint Fleur-Lominy - University of Maryland School of Medicine, Baltimore, USA )

Asciminib shows high molecular response, favourable safety in 2L CML-CP

Dr Jorge Cortes - Georgia Cancer Center, Augusta, USA

Asciminib shows high molecular response, favourable safety in 2L CML-CP ( Dr Jorge Cortes - Georgia Cancer Center, Augusta, USA )

Rocbrutinib shows strong responses in resistant CLL, including BTKi- and...

Prof Jennifer Woyach - The Ohio State University, Columbus, USA

Rocbrutinib shows strong responses in resistant CLL, including BTKi- and venetoclax-exposed patients ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )

Non-covalent BTK inhibitor pirtobrutinib shows promise as frontline therapy for...

Prof Jennifer Woyach - The Ohio State University, Columbus, USA

Non-covalent BTK inhibitor pirtobrutinib shows promise as frontline therapy for CLL/SLL ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )

Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive...

Prof Robert Orlowski - The University of Texas MD Anderson Cancer Center...

Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive frontline responses ( Prof Robert Orlowski - The University of Texas MD Anderson Cancer Center, Houston, USA )

Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG

Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA

Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG ( Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA )

More from ecancer